A Brazilian oil and gas company agreed to settle DOJ and SEC charges concerning the misrepresentation "of assets, infrastructure projects . . . and the nature of its relationships with its majority shareholder, the Brazilian government."
The former CEO of a Chilean-based chemical and mining company agreed to settle SEC charges for violating the books and records and internal accounting control provisions of the Foreign Corrupt Practices Act.
Global medical device manufacturer Zimmer Biomet Holdings, Inc. settled criminal and civil charges brought by the DOJ and SEC after the company was found to have violated a 2012 agreement settling previous Foreign Corrupt Practices Act allegations.
The SEC settled charges against a medical device manufacturer and its wholly owned subsidiary for engaging in "hundreds of sham transactions with distributors" in violation of the Foreign Corrupt Practices Act.
Request delivery of the Cadwalader Cabinet Newsletter.